首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1593443

自動注射器市場規模、佔有率、成長分析、按應用、按技術、按給藥途徑、按治療領域、按容量、按最終用戶、按地區 - 產業預測，2024-2031

Auto injector Market Size, Share, Growth Analysis, By Usage, By Technology, By Route of Administration, By Therapy Area, By Volume, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月13日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球自動注射器市場規模為71.6億美元，預計從2023年的83.7億美元成長到2031年的245.9億美元，在預測期內（2024-2031年）年複合成長率為14.42。

由於慢性病盛行率上升、自我管理設備需求增加以及技術不斷進步等幾個關鍵因素，全球自動注射器市場強勁成長。自動注射器有助於精確輸送藥物，例如治療過敏反應的腎上腺素和治療糖尿病的胰島素，具有使用者友善的操作、精確的劑量和提高患者對治療通訊協定。市場上的著名參與者包括製藥公司、醫療設備製造商和技術創新公司，它們都透過致力於設計、安全性和處理各種藥物的能力等產品屬性來爭奪市場佔有率。此外，法律規範、償付政策和專利保護等關鍵市場動態在塑造競爭格局方面發揮重要作用。尤其是美國自動注射器市場，預計在未來幾年將保持持續的年複合成長率（CAGR），這反映出這些設備在醫療保健環境中的接受度不斷提高。這項擴展凸顯了自動注射器被公認為有效疾病管理的重要工具，最終透過改善治療結果和醫療保健的自主權來使患者受益。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東、非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

SHL Medical AG
Ypsomed AG
Becton, Dickinson and Company（BD）
EQT IX（Recipharm AB）
West Pharmaceutical Services, Inc.
Molex（Phillips-Medisize）
Halozyme, Inc.
Owen Mumford Ltd.
AbbVie Inc.
Amgen Inc.
Novo Holdings A/S
Johnson & Johnson
Sanofi
GSK PLC
Gerresheimer AG
Medmix（Haselmaier）
SMC Ltd.（Oval Medical Technologies Ltd.）
Kaleo, Inc.
Solteam Incorporation Co., Ltd.
Elcam Drug Delivery Devices
Crossject
Jabil Inc.
Congruence Medical Solutions LLC
Midas Pharma GmbH

簡介目錄

Product Code: SQMIG35B2104

Global Autoinjectors Market size was valued at USD 7.16 billion in 2022 and is poised to grow from USD 8.37 billion in 2023 to USD 24.59 billion by 2031, growing at a CAGR of 14.42% during the forecast period (2024-2031).

The global auto injector market is witnessing robust growth driven by several key factors, including the rising incidence of chronic diseases, an elevated demand for self-administration devices, and ongoing technological advancements. Auto injectors, which facilitate the precise delivery of medications such as epinephrine for allergic reactions and insulin for diabetes management, provide significant advantages including user-friendly operation, accurate dosing, and enhanced patient adherence to treatment protocols. Notable players in the market encompass pharmaceutical firms, medical device manufacturers, and technology innovators, who vie for market share by focusing on product attributes like design, safety, and the ability to accommodate diverse medications. Additionally, crucial market dynamics-such as regulatory frameworks, reimbursement policies, and patent protections-play a significant role in shaping the competitive landscape. In particular, the U.S. auto injector market is forecasted to maintain a sustainable compound annual growth rate (CAGR) in the upcoming years, reflecting a growing acceptance of these devices in healthcare settings. This expansion underscores the increasing recognition of auto injectors as essential tools for effective disease management, ultimately benefiting patients through improved therapeutic outcomes and autonomy in their healthcare routines.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Autoinjectors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Autoinjectors Market Segmental Analysis

Global Autoinjectors Market is segmented by Usage, Technology, Route of Administration, Therapy Area, Volume, End User and Region. Based on Usage, the market is segmented into Disposable Autoinjectors, Reusable Autoinjectors. Based on Technology, the market is segmented into Manual Autoinjectors, Automatic Autoinjectors. Based on Route of Administration, the market is segmented into Subcutaneous, Intramuscular, Intravenous. Based on Therapy Area, the market is segmented into Rheumatoid Arthritis, Diabetes, Multiple Sclerosis, Anaphylaxis, Obesity, Other Therapy Areas. Based on Volume, the market is segmented into Up To 3ml, and Above 3ml. Based on End User, the market is segmented into Home Care Settings, Hospitals & Clinics, Ambulatory Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Autoinjectors Market

The rising incidence of chronic diseases, including rheumatoid arthritis, multiple sclerosis, diabetes, and allergies, serves as a pivotal market driver for the global autoinjectors market. As these conditions become increasingly prevalent, the demand for self-administration of medications is accelerating, highlighting the convenience and efficiency that autoinjectors provide. These devices empower patients, allowing for timely and accurate medication delivery, thereby enhancing treatment adherence and overall health outcomes. Moreover, the technological advancements in autoinjectors-such as needle safety features and user-friendly designs-further bolster their appeal, positioning them as essential tools for chronic disease management in an ever-evolving healthcare landscape.

Restraints in the Global Autoinjectors Market

The high cost of autoinjector devices serves as a significant market restraint, especially in emerging economies where access to healthcare solutions is often dictated by affordability. Patients in these regions may find the price point of autoinjectors prohibitive, leading to reluctance in adoption compared to more traditional and economically viable alternatives like syringes. This disparity not only limits the market potential for autoinjector manufacturers but also poses challenges for healthcare providers seeking to implement innovative treatment options. Consequently, the financial barrier associated with these advanced delivery systems can impede market growth and patient access, hindering the overall expansion of the global autoinjectors market.

Market Trends of the Global Autoinjectors Market

The Global Autoinjectors market is experiencing a significant trend towards self-administration of medications, driven by a growing patient preference for autonomy and convenience in treatment management. As patients increasingly seek to take control of their healthcare, the adoption of autoinjectors is on the rise, offering an efficient and user-friendly means to administer medications accurately. This empowerment fosters adherence to treatment regimens and enhances patient satisfaction. Furthermore, advancements in technology and design, coupled with an expanding range of therapies requiring autoinjectors, are anticipated to propel market growth, making it a pivotal segment in the broader healthcare landscape.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Supply Chain Analysis
Technology Analysis
Patent Analysis
Pricing Analysis
Trade Analysis
Customer & Buying Criteria Analysis
Regulatory landscape

Auto injector Market, By Usage

Market Overview
Disposable Autoinjectors
Reusable Autoinjectors

Auto injector Market, By Technology

Market Overview
Manual Autoinjectors
Automatic Autoinjectors

Auto injector Market, By Route Of Administration

Market Overview
Subcutaneous
Intramuscular
Intravenous

Auto injector Market, By Therapy Area

Market Overview
Rheumatoid Arthritis
Diabetes
Multiple Sclerosis
Anaphylaxis
Obesity
Other Therapy Areas

Auto injector Market, By Volume

Market Overview
Up To 3ml
Above 3ml

Auto injector Market, By End User

Market Overview
Home Care Settings
Hospitals & Clinics
Ambulatory Care Settings

Auto injector Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

SHL Medical AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EQT IX (Recipharm AB)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molex (Phillips-Medisize)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Halozyme, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Holdings A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GSK PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medmix (Haselmaier)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMC Ltd. (Oval Medical Technologies Ltd.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaleo, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solteam Incorporation Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elcam Drug Delivery Devices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Crossject
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jabil Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Congruence Medical Solutions LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Midas Pharma GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments